1 Market Overview

1.1 Product Overview and Scope of Insomnia Therapy

1.2 Classification of Insomnia Therapy by Type

1.2.1 Overview: Global Insomnia Therapy Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Insomnia Therapy Revenue Market Share by Type in 2021

1.2.3 Non-pharmacological Therapy

1.2.4 Pharmacological Therapy

1.3 Global Insomnia Therapy Market by Application

1.3.1 Overview: Global Insomnia Therapy Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospital

1.3.3 Ambulatory Surgical Center

1.3.4 Home Care

1.4 Global Insomnia Therapy Market Size & Forecast

1.5 Global Insomnia Therapy Market Size and Forecast by Region

1.5.1 Global Insomnia Therapy Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Insomnia Therapy Market Size by Region, (2017-2022)

1.5.3 North America Insomnia Therapy Market Size and Prospect (2017-2028)

1.5.4 Europe Insomnia Therapy Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Insomnia Therapy Market Size and Prospect (2017-2028)

1.5.6 South America Insomnia Therapy Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Insomnia Therapy Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Insomnia Therapy Market Drivers

1.6.2 Insomnia Therapy Market Restraints

1.6.3 Insomnia Therapy Trends Analysis

2 Company Profiles

2.1 Merck & Co.

2.1.1 Merck & Co. Details

2.1.2 Merck & Co. Major Business

2.1.3 Merck & Co. Insomnia Therapy Product and Solutions

2.1.4 Merck & Co. Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Merck & Co. Recent Developments and Future Plans

2.2 Sanofi

2.2.1 Sanofi Details

2.2.2 Sanofi Major Business

2.2.3 Sanofi Insomnia Therapy Product and Solutions

2.2.4 Sanofi Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Sanofi Recent Developments and Future Plans

2.3 Pfizer

2.3.1 Pfizer Details

2.3.2 Pfizer Major Business

2.3.3 Pfizer Insomnia Therapy Product and Solutions

2.3.4 Pfizer Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Pfizer Recent Developments and Future Plans

2.4 Takeda Pharmaceutical Company Ltd.

2.4.1 Takeda Pharmaceutical Company Ltd. Details

2.4.2 Takeda Pharmaceutical Company Ltd. Major Business

2.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product and Solutions

2.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans

2.5 Purdue Pharmaceuticals L.P.

2.5.1 Purdue Pharmaceuticals L.P. Details

2.5.2 Purdue Pharmaceuticals L.P. Major Business

2.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Product and Solutions

2.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Purdue Pharmaceuticals L.P. Recent Developments and Future Plans

2.6 Eisai, Co. Ltd.

2.6.1 Eisai, Co. Ltd. Details

2.6.2 Eisai, Co. Ltd. Major Business

2.6.3 Eisai, Co. Ltd. Insomnia Therapy Product and Solutions

2.6.4 Eisai, Co. Ltd. Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Eisai, Co. Ltd. Recent Developments and Future Plans

2.7 Meda Consumer Healthcare

2.7.1 Meda Consumer Healthcare Details

2.7.2 Meda Consumer Healthcare Major Business

2.7.3 Meda Consumer Healthcare Insomnia Therapy Product and Solutions

2.7.4 Meda Consumer Healthcare Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Meda Consumer Healthcare Recent Developments and Future Plans

2.8 Pernix Therapeutics

2.8.1 Pernix Therapeutics Details

2.8.2 Pernix Therapeutics Major Business

2.8.3 Pernix Therapeutics Insomnia Therapy Product and Solutions

2.8.4 Pernix Therapeutics Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Pernix Therapeutics Recent Developments and Future Plans

2.9 Vanda Pharmaceuticals

2.9.1 Vanda Pharmaceuticals Details

2.9.2 Vanda Pharmaceuticals Major Business

2.9.3 Vanda Pharmaceuticals Insomnia Therapy Product and Solutions

2.9.4 Vanda Pharmaceuticals Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Vanda Pharmaceuticals Recent Developments and Future Plans

2.10 ECR Pharmaceuticals

2.10.1 ECR Pharmaceuticals Details

2.10.2 ECR Pharmaceuticals Major Business

2.10.3 ECR Pharmaceuticals Insomnia Therapy Product and Solutions

2.10.4 ECR Pharmaceuticals Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 ECR Pharmaceuticals Recent Developments and Future Plans

2.11 Fidia Farmaceutici

2.11.1 Fidia Farmaceutici Details

2.11.2 Fidia Farmaceutici Major Business

2.11.3 Fidia Farmaceutici Insomnia Therapy Product and Solutions

2.11.4 Fidia Farmaceutici Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Fidia Farmaceutici Recent Developments and Future Plans

2.12 Dainippon Sumitomo

2.12.1 Dainippon Sumitomo Details

2.12.2 Dainippon Sumitomo Major Business

2.12.3 Dainippon Sumitomo Insomnia Therapy Product and Solutions

2.12.4 Dainippon Sumitomo Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Dainippon Sumitomo Recent Developments and Future Plans

2.13 Biocodex

2.13.1 Biocodex Details

2.13.2 Biocodex Major Business

2.13.3 Biocodex Insomnia Therapy Product and Solutions

2.13.4 Biocodex Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Biocodex Recent Developments and Future Plans

2.14 Eli Lilly and Company

2.14.1 Eli Lilly and Company Details

2.14.2 Eli Lilly and Company Major Business

2.14.3 Eli Lilly and Company Insomnia Therapy Product and Solutions

2.14.4 Eli Lilly and Company Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Eli Lilly and Company Recent Developments and Future Plans

2.15 Ebb Therapeutics

2.15.1 Ebb Therapeutics Details

2.15.2 Ebb Therapeutics Major Business

2.15.3 Ebb Therapeutics Insomnia Therapy Product and Solutions

2.15.4 Ebb Therapeutics Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Ebb Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Insomnia Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Insomnia Therapy Players Market Share in 2021

3.2.2 Top 10 Insomnia Therapy Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Insomnia Therapy Players Head Office, Products and Services Provided

3.4 Insomnia Therapy Mergers & Acquisitions

3.5 Insomnia Therapy New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Insomnia Therapy Revenue and Market Share by Type (2017-2022)

4.2 Global Insomnia Therapy Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Insomnia Therapy Revenue Market Share by Application (2017-2022)

5.2 Global Insomnia Therapy Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Insomnia Therapy Revenue by Type (2017-2028)

6.2 North America Insomnia Therapy Revenue by Application (2017-2028)

6.3 North America Insomnia Therapy Market Size by Country

6.3.1 North America Insomnia Therapy Revenue by Country (2017-2028)

6.3.2 United States Insomnia Therapy Market Size and Forecast (2017-2028)

6.3.3 Canada Insomnia Therapy Market Size and Forecast (2017-2028)

6.3.4 Mexico Insomnia Therapy Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Insomnia Therapy Revenue by Type (2017-2028)

7.2 Europe Insomnia Therapy Revenue by Application (2017-2028)

7.3 Europe Insomnia Therapy Market Size by Country

7.3.1 Europe Insomnia Therapy Revenue by Country (2017-2028)

7.3.2 Germany Insomnia Therapy Market Size and Forecast (2017-2028)

7.3.3 France Insomnia Therapy Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Insomnia Therapy Market Size and Forecast (2017-2028)

7.3.5 Russia Insomnia Therapy Market Size and Forecast (2017-2028)

7.3.6 Italy Insomnia Therapy Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Insomnia Therapy Revenue by Type (2017-2028)

8.2 Asia-Pacific Insomnia Therapy Revenue by Application (2017-2028)

8.3 Asia-Pacific Insomnia Therapy Market Size by Region

8.3.1 Asia-Pacific Insomnia Therapy Revenue by Region (2017-2028)

8.3.2 China Insomnia Therapy Market Size and Forecast (2017-2028)

8.3.3 Japan Insomnia Therapy Market Size and Forecast (2017-2028)

8.3.4 South Korea Insomnia Therapy Market Size and Forecast (2017-2028)

8.3.5 India Insomnia Therapy Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Insomnia Therapy Market Size and Forecast (2017-2028)

8.3.7 Australia Insomnia Therapy Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Insomnia Therapy Revenue by Type (2017-2028)

9.2 South America Insomnia Therapy Revenue by Application (2017-2028)

9.3 South America Insomnia Therapy Market Size by Country

9.3.1 South America Insomnia Therapy Revenue by Country (2017-2028)

9.3.2 Brazil Insomnia Therapy Market Size and Forecast (2017-2028)

9.3.3 Argentina Insomnia Therapy Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Insomnia Therapy Revenue by Type (2017-2028)

10.2 Middle East & Africa Insomnia Therapy Revenue by Application (2017-2028)

10.3 Middle East & Africa Insomnia Therapy Market Size by Country

10.3.1 Middle East & Africa Insomnia Therapy Revenue by Country (2017-2028)

10.3.2 Turkey Insomnia Therapy Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Insomnia Therapy Market Size and Forecast (2017-2028)

10.3.4 UAE Insomnia Therapy Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Insomnia Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Insomnia Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Insomnia Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Insomnia Therapy Revenue (USD Million) by Region (2017-2022)

Table 5. Global Insomnia Therapy Revenue Market Share by Region (2023-2028)

Table 6. Merck & Co. Corporate Information, Head Office, and Major Competitors

Table 7. Merck & Co. Major Business

Table 8. Merck & Co. Insomnia Therapy Product and Solutions

Table 9. Merck & Co. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Sanofi Corporate Information, Head Office, and Major Competitors

Table 11. Sanofi Major Business

Table 12. Sanofi Insomnia Therapy Product and Solutions

Table 13. Sanofi Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Pfizer Corporate Information, Head Office, and Major Competitors

Table 15. Pfizer Major Business

Table 16. Pfizer Insomnia Therapy Product and Solutions

Table 17. Pfizer Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Takeda Pharmaceutical Company Ltd. Corporate Information, Head Office, and Major Competitors

Table 19. Takeda Pharmaceutical Company Ltd. Major Business

Table 20. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product and Solutions

Table 21. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Purdue Pharmaceuticals L.P. Corporate Information, Head Office, and Major Competitors

Table 23. Purdue Pharmaceuticals L.P. Major Business

Table 24. Purdue Pharmaceuticals L.P. Insomnia Therapy Product and Solutions

Table 25. Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Eisai, Co. Ltd. Corporate Information, Head Office, and Major Competitors

Table 27. Eisai, Co. Ltd. Major Business

Table 28. Eisai, Co. Ltd. Insomnia Therapy Product and Solutions

Table 29. Eisai, Co. Ltd. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Meda Consumer Healthcare Corporate Information, Head Office, and Major Competitors

Table 31. Meda Consumer Healthcare Major Business

Table 32. Meda Consumer Healthcare Insomnia Therapy Product and Solutions

Table 33. Meda Consumer Healthcare Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Pernix Therapeutics Corporate Information, Head Office, and Major Competitors

Table 35. Pernix Therapeutics Major Business

Table 36. Pernix Therapeutics Insomnia Therapy Product and Solutions

Table 37. Pernix Therapeutics Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Vanda Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 39. Vanda Pharmaceuticals Major Business

Table 40. Vanda Pharmaceuticals Insomnia Therapy Product and Solutions

Table 41. Vanda Pharmaceuticals Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. ECR Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 43. ECR Pharmaceuticals Major Business

Table 44. ECR Pharmaceuticals Insomnia Therapy Product and Solutions

Table 45. ECR Pharmaceuticals Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Fidia Farmaceutici Corporate Information, Head Office, and Major Competitors

Table 47. Fidia Farmaceutici Major Business

Table 48. Fidia Farmaceutici Insomnia Therapy Product and Solutions

Table 49. Fidia Farmaceutici Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Dainippon Sumitomo Corporate Information, Head Office, and Major Competitors

Table 51. Dainippon Sumitomo Major Business

Table 52. Dainippon Sumitomo Insomnia Therapy Product and Solutions

Table 53. Dainippon Sumitomo Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Biocodex Corporate Information, Head Office, and Major Competitors

Table 55. Biocodex Major Business

Table 56. Biocodex Insomnia Therapy Product and Solutions

Table 57. Biocodex Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors

Table 59. Eli Lilly and Company Major Business

Table 60. Eli Lilly and Company Insomnia Therapy Product and Solutions

Table 61. Eli Lilly and Company Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Ebb Therapeutics Corporate Information, Head Office, and Major Competitors

Table 63. Ebb Therapeutics Major Business

Table 64. Ebb Therapeutics Insomnia Therapy Product and Solutions

Table 65. Ebb Therapeutics Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Global Insomnia Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 67. Global Insomnia Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 68. Breakdown of Insomnia Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Insomnia Therapy Players Head Office, Products and Services Provided

Table 70. Insomnia Therapy Mergers & Acquisitions in the Past Five Years

Table 71. Insomnia Therapy New Entrants and Expansion Plans

Table 72. Global Insomnia Therapy Revenue (USD Million) by Type (2017-2022)

Table 73. Global Insomnia Therapy Revenue Share by Type (2017-2022)

Table 74. Global Insomnia Therapy Revenue Forecast by Type (2023-2028)

Table 75. Global Insomnia Therapy Revenue by Application (2017-2022)

Table 76. Global Insomnia Therapy Revenue Forecast by Application (2023-2028)

Table 77. North America Insomnia Therapy Revenue by Type (2017-2022) & (USD Million)

Table 78. North America Insomnia Therapy Revenue by Type (2023-2028) & (USD Million)

Table 79. North America Insomnia Therapy Revenue by Application (2017-2022) & (USD Million)

Table 80. North America Insomnia Therapy Revenue by Application (2023-2028) & (USD Million)

Table 81. North America Insomnia Therapy Revenue by Country (2017-2022) & (USD Million)

Table 82. North America Insomnia Therapy Revenue by Country (2023-2028) & (USD Million)

Table 83. Europe Insomnia Therapy Revenue by Type (2017-2022) & (USD Million)

Table 84. Europe Insomnia Therapy Revenue by Type (2023-2028) & (USD Million)

Table 85. Europe Insomnia Therapy Revenue by Application (2017-2022) & (USD Million)

Table 86. Europe Insomnia Therapy Revenue by Application (2023-2028) & (USD Million)

Table 87. Europe Insomnia Therapy Revenue by Country (2017-2022) & (USD Million)

Table 88. Europe Insomnia Therapy Revenue by Country (2023-2028) & (USD Million)

Table 89. Asia-Pacific Insomnia Therapy Revenue by Type (2017-2022) & (USD Million)

Table 90. Asia-Pacific Insomnia Therapy Revenue by Type (2023-2028) & (USD Million)

Table 91. Asia-Pacific Insomnia Therapy Revenue by Application (2017-2022) & (USD Million)

Table 92. Asia-Pacific Insomnia Therapy Revenue by Application (2023-2028) & (USD Million)

Table 93. Asia-Pacific Insomnia Therapy Revenue by Region (2017-2022) & (USD Million)

Table 94. Asia-Pacific Insomnia Therapy Revenue by Region (2023-2028) & (USD Million)

Table 95. South America Insomnia Therapy Revenue by Type (2017-2022) & (USD Million)

Table 96. South America Insomnia Therapy Revenue by Type (2023-2028) & (USD Million)

Table 97. South America Insomnia Therapy Revenue by Application (2017-2022) & (USD Million)

Table 98. South America Insomnia Therapy Revenue by Application (2023-2028) & (USD Million)

Table 99. South America Insomnia Therapy Revenue by Country (2017-2022) & (USD Million)

Table 100. South America Insomnia Therapy Revenue by Country (2023-2028) & (USD Million)

Table 101. Middle East & Africa Insomnia Therapy Revenue by Type (2017-2022) & (USD Million)

Table 102. Middle East & Africa Insomnia Therapy Revenue by Type (2023-2028) & (USD Million)

Table 103. Middle East & Africa Insomnia Therapy Revenue by Application (2017-2022) & (USD Million)

Table 104. Middle East & Africa Insomnia Therapy Revenue by Application (2023-2028) & (USD Million)

Table 105. Middle East & Africa Insomnia Therapy Revenue by Country (2017-2022) & (USD Million)

Table 106. Middle East & Africa Insomnia Therapy Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Insomnia Therapy Picture

Figure 2. Global Insomnia Therapy Revenue Market Share by Type in 2021

Figure 3. Non-pharmacological Therapy

Figure 4. Pharmacological Therapy

Figure 5. Insomnia Therapy Revenue Market Share by Application in 2021

Figure 6. Hospital Picture

Figure 7. Ambulatory Surgical Center Picture

Figure 8. Home Care Picture

Figure 9. Global Insomnia Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Insomnia Therapy Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Insomnia Therapy Revenue Market Share by Region (2017-2028)

Figure 12. Global Insomnia Therapy Revenue Market Share by Region in 2021

Figure 13. North America Insomnia Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Insomnia Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Insomnia Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Insomnia Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Insomnia Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Insomnia Therapy Market Drivers

Figure 19. Insomnia Therapy Market Restraints

Figure 20. Insomnia Therapy Market Trends

Figure 21. Merck & Co. Recent Developments and Future Plans

Figure 22. Sanofi Recent Developments and Future Plans

Figure 23. Pfizer Recent Developments and Future Plans

Figure 24. Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans

Figure 25. Purdue Pharmaceuticals L.P. Recent Developments and Future Plans

Figure 26. Eisai, Co. Ltd. Recent Developments and Future Plans

Figure 27. Meda Consumer Healthcare Recent Developments and Future Plans

Figure 28. Pernix Therapeutics Recent Developments and Future Plans

Figure 29. Vanda Pharmaceuticals Recent Developments and Future Plans

Figure 30. ECR Pharmaceuticals Recent Developments and Future Plans

Figure 31. Fidia Farmaceutici Recent Developments and Future Plans

Figure 32. Dainippon Sumitomo Recent Developments and Future Plans

Figure 33. Biocodex Recent Developments and Future Plans

Figure 34. Eli Lilly and Company Recent Developments and Future Plans

Figure 35. Ebb Therapeutics Recent Developments and Future Plans

Figure 36. Global Insomnia Therapy Revenue Share by Players in 2021

Figure 37. Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 38. Global Top 3 Players Insomnia Therapy Revenue Market Share in 2021

Figure 39. Global Top 10 Players Insomnia Therapy Revenue Market Share in 2021

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 41. Global Insomnia Therapy Revenue Share by Type in 2021

Figure 42. Global Insomnia Therapy Market Share Forecast by Type (2023-2028)

Figure 43. Global Insomnia Therapy Revenue Share by Application in 2021

Figure 44. Global Insomnia Therapy Market Share Forecast by Application (2023-2028)

Figure 45. North America Insomnia Therapy Sales Market Share by Type (2017-2028)

Figure 46. North America Insomnia Therapy Sales Market Share by Application (2017-2028)

Figure 47. North America Insomnia Therapy Revenue Market Share by Country (2017-2028)

Figure 48. United States Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Canada Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Mexico Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Europe Insomnia Therapy Sales Market Share by Type (2017-2028)

Figure 52. Europe Insomnia Therapy Sales Market Share by Application (2017-2028)

Figure 53. Europe Insomnia Therapy Revenue Market Share by Country (2017-2028)

Figure 54. Germany Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. France Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. United Kingdom Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Russia Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Italy Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Asia-Pacific Insomnia Therapy Sales Market Share by Type (2017-2028)

Figure 60. Asia-Pacific Insomnia Therapy Sales Market Share by Application (2017-2028)

Figure 61. Asia-Pacific Insomnia Therapy Revenue Market Share by Region (2017-2028)

Figure 62. China Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Japan Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South Korea Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. India Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Southeast Asia Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Australia Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South America Insomnia Therapy Sales Market Share by Type (2017-2028)

Figure 69. South America Insomnia Therapy Sales Market Share by Application (2017-2028)

Figure 70. South America Insomnia Therapy Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East and Africa Insomnia Therapy Sales Market Share by Type (2017-2028)

Figure 74. Middle East and Africa Insomnia Therapy Sales Market Share by Application (2017-2028)

Figure 75. Middle East and Africa Insomnia Therapy Revenue Market Share by Country (2017-2028)

Figure 76. Turkey Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Saudi Arabia Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. UAE Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source